Mithra Pharmaceuticals SA (MITPF)
6.75
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Mithra Pharmaceuticals Shareholders Equity (Quarterly): -9.487M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -9.487M |
| June 30, 2023 | -9.487M |
| December 31, 2022 | 36.13M |
| June 30, 2022 | 37.74M |
| June 30, 2022 | 37.74M |
| December 31, 2021 | 38.31M |
| June 30, 2021 | 116.72M |
| June 30, 2021 | 116.72M |
| December 31, 2020 | 194.01M |
| June 30, 2020 | 210.90M |
| June 30, 2020 | 210.90M |
| December 31, 2019 | 182.92M |
| June 30, 2019 | 72.69M |
| June 30, 2019 | 72.69M |
| Date | Value |
|---|---|
| December 31, 2018 | 172.61M |
| June 30, 2018 | 147.81M |
| June 30, 2018 | 147.81M |
| December 31, 2017 | 104.23M |
| June 30, 2017 | 114.38M |
| June 30, 2017 | 114.38M |
| December 31, 2016 | 98.33M |
| June 30, 2016 | 120.30M |
| June 30, 2016 | 120.30M |
| December 31, 2015 | 139.28M |
| June 30, 2015 | 60.76M |
| June 30, 2015 | 60.76M |
| December 31, 2014 | 6.717M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-9.487M
Minimum
Jun 2023
210.90M
Maximum
Jun 2020
93.46M
Average
72.69M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
| Galapagos NV | 3.126B |
| UCB SA | 9.921B |
| Nyxoah SA | 94.16M |
| Celyad Oncology SA | 1.107M |
| MDxHealth SA | -0.973M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 407.25M |
| Total Liabilities (Quarterly) | 416.74M |
| Debt to Equity Ratio | -19.15 |
| Current Ratio | 1.043 |
| Net Debt Paydown Yield | 1.08% |